Breast Cancer. Malignant Neoplasm of Breast
Conditions
Interventions
Intervention 1: At the first time of beginning radiotherapy we will recommend to patients use the cream which prepared from oat extract, three times a day each 8 hours daily (TDS), in the radiotherap
Treatment - Drugs
Placebo
At the first time of beginning radiotherapy we will recommend to patients use the cream which prepared from oat extract, three times a day each 8 hours daily (TDS), in the radiotherapy area, amount o
In the control group patients will use placebo (extract-free cream base).
Sponsors
Tehran University of Medical Science
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria: Women with breast cancer; Without any skin lesion. Exclusion criteria: Patients with uncontrolled diabetes; Acquired immunodeficiency syndrome; A history of allergy to medicinal plants.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The grade of skin reaction caused by radioytherapy. Timepoint: At the intervals of 10 days after initiation of treatment , 28 days after initiation of treatment, on the last day of radiotherapy and after that in two times with one week interval, after the end of radiotherapy participants will be followed up. Method of measurement: Using the RTOG questionnaire and researcher-made questionnaire.;Erythema. Timepoint: At the intervals of 10 days after initiation of treatment , 28 days after initiation of treatment, on the last day of radiotherapy and after that in two times with one week interval, after the end of radiotherapy participants will be followed up. Method of measurement: Using the RTOG questionnaire and researcher-made questionnaire.;Dry desquamation. Timepoint: At the intervals of 10 days after initiation of treatment , 28 days after initiation of treatment, on the last day of radiotherapy and after that in two times with one week interval, after the end of radiotherapy participants will be followed up. Method of measurement: Using the RTOG questionnaire and researcher-made questionnaire.;Itching. Timepoint: At the intervals of 10 days after initiation of treatment , 28 days after initiation of treatment, on the last day of radiotherapy and after that in two times with one week interval, after the end of radiotherapy participants will be followed up. Method of measurement: Ask the patient and using a researcher-made questionnaire.;Burning sensation. Timepoint: At the intervals of 10 days after initiation of treatment , 28 days after initiation of treatment, on the last day of radiotherapy and after that in two times with one week interval, after the end of radiotherapy participants will be followed up. Method of measurement: Ask the patient and using a researcher-made questionnaire.;Changes in daily activities. Timepoint: At the intervals of 10 days after initiation of treatment , 28 days after initiation of treatment, on the last day of radiotherapy a | — |
Secondary
| Measure | Time frame |
|---|---|
| Patchy and Distribution Moist Desquamation. Timepoint: At the intervals of 10 days after initiation of treatment , 28 days after initiation of treatment, on the last day of radiotherapy and after that in two times with one week interval, after the end of radiotherapy participants will be followed up. Method of measurement: Examination by a physician.;Drainage, Infection, Cellulitis. Timepoint: At the intervals of 10 days after initiation of treatment , 28 days after initiation of treatment, on the last day of radiotherapy and after that in two times with one week interval, after the end of radiotherapy participants will be followed up. Method of measurement: Examination by a physician. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShahrzad ghiyasvandiyan
Tehran University of Medical Sciences,School of Nursing and Midwifery
Outcome results
None listed